» Articles » PMID: 28475229

Nomenclature and Definition in Asymmetric Regional Body Overgrowth

Abstract

We designate a novel term "isolated lateralized overgrowth" (ILO) for the findings previously described as "isolated hemihypertrophy" and "isolated hemihyperplasia." ILO is defined as lateralized overgrowth in the absence of a recognized pattern of malformations, dysplasia, or morphologic variants. ILO is likely genetically heterogeneous. Further study is required to determine more of the underlying genetic etiologies and potential associations with currently unrecognized patterns of malformation.

Citing Articles

Isolated Lateralized Overgrowth - Phenotypic Spectrum and Molecular Alterations.

Yadav S, Madhumita R, Gupta N, Chauhan S, Kusmakar S, Balakrishnan P Indian J Pediatr. 2024; .

PMID: 39425824 DOI: 10.1007/s12098-024-05273-0.


Progressive vascular tumor in infant: A case report and literature review of PIK3CA vascular malformation.

Medina A, Zima L, Atkinson A, Menon N, Bhattacharjee M, Bonfante E Childs Nerv Syst. 2024; 40(4):1005-1010.

PMID: 38265477 DOI: 10.1007/s00381-024-06290-2.


Investigation of 11p15.5 Methylation Defects Associated with Beckwith-Wiedemann Spectrum and Embryonic Tumor Risk in Lateralized Overgrowth Patients.

Tuysuz B, Bozlak S, Alkaya D, Ocak S, Kasap B, Sunamak Cifci E Cancers (Basel). 2023; 15(6).

PMID: 36980758 PMC: 10046725. DOI: 10.3390/cancers15061872.


Performance Metrics of the Scoring System for the Diagnosis of the Beckwith-Wiedemann Spectrum (BWSp) and Its Correlation with Cancer Development.

Luca M, Carli D, Cardaropoli S, Milani D, Cocchi G, Leoni C Cancers (Basel). 2023; 15(3).

PMID: 36765732 PMC: 9913441. DOI: 10.3390/cancers15030773.


Lateralized overgrowth as a guiding sign of abdominal neoplasms for pediatric orthopedic surgeons.

Parada-Avendano I, Salvador H, Garcia R, Martorell-Sampol L, Fontecha C, Torner-Rubies F Jt Dis Relat Surg. 2023; 34(1):3-8.

PMID: 36700257 PMC: 9903098. DOI: 10.52312/jdrs.2023.903.


References
1.
Maas S, Vansenne F, Kadouch D, Ibrahim A, Bliek J, Hopman S . Phenotype, cancer risk, and surveillance in Beckwith-Wiedemann syndrome depending on molecular genetic subgroups. Am J Med Genet A. 2016; 170(9):2248-60. DOI: 10.1002/ajmg.a.37801. View

2.
Mussa A, Molinatto C, Baldassarre G, Riberi E, Russo S, Larizza L . Cancer Risk in Beckwith-Wiedemann Syndrome: A Systematic Review and Meta-Analysis Outlining a Novel (Epi)Genotype Specific Histotype Targeted Screening Protocol. J Pediatr. 2016; 176:142-149.e1. DOI: 10.1016/j.jpeds.2016.05.038. View

3.
Bazzocchi A, Ponti F, Albisinni U, Battista G, Guglielmi G . DXA: Technical aspects and application. Eur J Radiol. 2016; 85(8):1481-92. DOI: 10.1016/j.ejrad.2016.04.004. View

4.
Clericuzio C, Martin R . Diagnostic criteria and tumor screening for individuals with isolated hemihyperplasia. Genet Med. 2009; 11(3):220-2. PMC: 3111026. DOI: 10.1097/GIM.0b013e31819436cf. View

5.
Russo S, Calzari L, Mussa A, Mainini E, Cassina M, Di Candia S . A multi-method approach to the molecular diagnosis of overt and borderline 11p15.5 defects underlying Silver-Russell and Beckwith-Wiedemann syndromes. Clin Epigenetics. 2016; 8:23. PMC: 4772365. DOI: 10.1186/s13148-016-0183-8. View